WE-REACH is announcing fast track funding for early-stage projects aimed at developing biosensors for COVID-19 open to researchers in the Pacific Northwest. This one-time opportunity through the NIH is part of the to detect the virus or other biomarkers in nasal and oral cavities or skin.
This funding is intended to support innovators with promising technologies for research and early development (R&D) by providing support and project tracking. Each applicant may request up to $434K for 2 years.
More information about RADx-Rad funding opportunities for other groups: “Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity”
- /we-reach/ (Pre-SBIR institutional researchers)
- (U18 for cooperative submissions)
- (R44 SBIR Phase II)
- (R42 STTR Phase II)
For more information and submission information follow this link. Given the rapid nature of this funding opportunity, there will be additional updates on how to apply soon.
On August 21st, Declarations of Intent (DOIs) are due for WE-REACH Project Funding and Support. The call is open for projects led by 91爆料 PIs or collaborators with 91爆料 Co-PIs. The intent is to assist investigators in completing proof of product concept validation and securing follow-on funding. For more information, see our